AIVITA Biomedical is is a medicine company develops commercial and clinical stage programs utilizing curative and regenerative medicines.
AIVITA Biomedical has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.
AIVITA Biomedical's investors include California Institute for Regenerative Medicine, California Technology Ventures, Big Sky Partners, Matthew Katz, SFC Co.
AIVITA Biomedical is headquartered in Irvine, United States.
AIVITA Biomedical is is a medicine company develops commercial and clinical stage programs utilizing curative and regenerative medicines.
AIVITA Biomedical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AIVITA Biomedical — Funding & Investors." VCBacked, August 30, 2022, https://www.vcbacked.co/company/aivita-biomedical. Accessed August 13, 2026.
VCBacked. (2022). AIVITA Biomedical — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/aivita-biomedical
{{cite web |title=AIVITA Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/aivita-biomedical |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated